Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
September 5, 2020
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
Vincenzo Nasca, Marta Chiaravalli, Geny Piro, et al.
Amino Acids
|
October 21, 2016
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat
Carmine Carbone, Elena Di Gennaro, Geny Piro, et al.
International Journal of Molecular Sciences
|
February 2, 2018
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carmine Carbone, Geny Piro, Valeria Merz, et al.
International Journal of Molecular Sciences
|
October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
Journal of Cellular Physiology
|
June 11, 2011
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
Francesca Bruzzese, Alessandra Leone, Monia Rocco, et al.
Cancers
|
October 30, 2019
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
Geny Piro, Carmine Carbone, Luisa Carbognin, et al.
Cancers
|
February 10, 2024
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, et al.
European Journal of Neurology
|
July 4, 2023
Inflammatory profile in mitochondrial diseases: A cohort study
Guido Primiano, Domenico Plantone, Geny Piro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 22, 2020
The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients' Age: A Systematic Review and Meta-Analysis
Chiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Frontiers in Immunology
|
May 27, 2024
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma
Brigida Anna Maiorano, Giovanni Schinzari, Carmine Carbone, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
September 5, 2020
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
Vincenzo Nasca, Marta Chiaravalli, Geny Piro, et al.
Amino Acids
|
October 21, 2016
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat
Carmine Carbone, Elena Di Gennaro, Geny Piro, et al.
International Journal of Molecular Sciences
|
February 2, 2018
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carmine Carbone, Geny Piro, Valeria Merz, et al.
International Journal of Molecular Sciences
|
October 28, 2018
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, et al.
Journal of Cellular Physiology
|
June 11, 2011
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
Francesca Bruzzese, Alessandra Leone, Monia Rocco, et al.
Cancers
|
October 30, 2019
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
Geny Piro, Carmine Carbone, Luisa Carbognin, et al.
Cancers
|
February 10, 2024
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, et al.
European Journal of Neurology
|
July 4, 2023
Inflammatory profile in mitochondrial diseases: A cohort study
Guido Primiano, Domenico Plantone, Geny Piro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 22, 2020
The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients' Age: A Systematic Review and Meta-Analysis
Chiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Frontiers in Immunology
|
May 27, 2024
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma
Brigida Anna Maiorano, Giovanni Schinzari, Carmine Carbone, et al.
Page
of 6